thiazoles has been researched along with Scoliosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiel, J; Berteloot, L; Blanc, E; Blanc, T; Boccara, O; Boddaert, N; Bole-Feysot, C; Broissand, C; Canaud, G; Chaussain, C; Cormier-Daire, V; Duong, JP; Grenier, N; Guibaud, L; Hoguin, C; Johnson, SC; Joly, D; Knebelmann, B; Ladraa, S; Laroche-Raynaud, C; Legendre, C; Lyonnet, S; Magassa, S; Martinez, F; Merville, P; Michot, C; Pannier, S; Picard, A; Rabia, SH; Sadoine, J; Sarnacki, S; Slimani, L; Soupre, V; Terzi, F; Venot, Q; Yamaguchi, J | 1 |
1 trial(s) available for thiazoles and Scoliosis
| Article | Year |
|---|---|
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Topics: Adult; Animals; Child; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Heart Failure; HeLa Cells; Humans; Lipoma; Male; Mice; Molecular Targeted Therapy; Musculoskeletal Abnormalities; Nevus; Phenotype; Scoliosis; Sirolimus; Syndrome; Thiazoles; Vascular Malformations; Vascular Neoplasms | 2018 |